Company Overview
Ping An Biomedical Co., Ltd. operates through its subsidiaries to provide comprehensive supply chain management services within the apparel industry, specifically serving markets in China, Hong Kong, Cambodia, and Europe. The company's operational scope encompasses critical functions such as market trend analysis, product design and development, raw material sourcing, production oversight, and quality control. This entity functions within the Consumer Cyclical sector, specifically categorized under the Textile Manufacturing industry, which implies its performance is closely tied to consumer discretionary spending and global fashion demand cycles. The company currently maintains a market capitalization of $16.53M and generates annual revenue of $34.15M, while employing a workforce of 7 individuals. These valuation and revenue figures indicate that the company operates at a micro-cap scale with a relatively small revenue base, suggesting a specialized niche operation rather than a diversified industrial giant. The extremely low employee count relative to the geographic scope of operations hints at a highly automated or asset-light business model, although the financial data presents conflicting signals regarding operational costs. The disparity between the modest market cap and the specific regional footprint suggests a company that may be struggling to capture value commensurate with its international reach or is facing significant structural headwinds that suppress its market valuation.
Financial Health
The company reported a trailing twelve-month revenue of $34.15M, yet it incurred a net loss of $-12,829,206 and an EBITDA of $-14,695,886, revealing a severe disconnect between top-line sales and profitability. The substantial gap between the $34.15M in revenue and the negative net income of over $12 million indicates a highly inefficient cost structure where operating expenses and cost of goods sold significantly erode gross profits. Free cash flow stands at a negative $-59,241,688, which signifies a critical lack of financial flexibility, as the company is burning cash faster than it can generate liquidity from its core operations. Analysis of the three primary margins shows a gross margin of 2.8%, an operating margin of -69.6%, and a profit margin of -37.6%, all of which point to extreme operational inefficiency and an inability to cover fixed costs. The balance sheet presents a leveraged position with total debt of $10.47M against only $1.17M in cash, resulting in a debt-to-equity ratio of 23.14, which indicates high financial risk and limited capacity to withstand economic downturns. Despite the high leverage, the current ratio remains at 2.76, suggesting that the company currently holds sufficient current assets to cover short-term liabilities, though this liquidity is likely being consumed by ongoing operational losses. Return on Equity is recorded at -67.4% and Return on Assets at -14.7%, metrics that reveal management is effectively destroying shareholder value and utilizing assets unproductively to generate negative returns.
Valuation Assessment
The P/E Ratio (TTM) and Forward P/E are both listed as N/A, which implies that the company is currently unprofitable and that traditional earnings-based valuation metrics are not applicable for assessing its expected earnings trajectory at this time. The price-to-book ratio stands at 0.42, indicating that the stock is trading at a significant discount to its net asset value, a situation often found in distressed or turnaround scenarios rather than premium growth stocks. Alternative valuation metrics such as the price-to-sales ratio of 0.48 and an EV/EBITDA of -0.85 suggest that the market is pricing the company based on revenue multiples rather than earnings, reflecting the uncertainty surrounding future profitability. The stock has experienced extreme volatility over the past year, with a 52-week high of $5.40 and a 52-week low of $0.13, meaning the current price sits very close to the bottom of this trading range. The beta value is listed as N/A, which precludes a direct assessment of price volatility relative to the broader market using standard beta calculations, though the wide price range indicates high sensitivity to market sentiment. The negative EV/EBITDA further reinforces that the company's enterprise value is heavily influenced by its negative earnings profile rather than operational leverage.
Growth & Income
Revenue growth year-over-year is -62.0%, while earnings growth is N/A due to the lack of profitability, indicating that the company is shrinking in terms of sales and simultaneously destroying value for shareholders. Since the company is not a dividend payer, there is no dividend yield or payout ratio to evaluate for sustainability, meaning all retained earnings are effectively consumed by losses rather than being reinvested or distributed. The absence of positive earnings growth combined with a steep decline in revenue suggests that the business model is facing structural challenges or a significant loss of market share in its apparel supply chain segments. The overall growth and income profile is characterized by contraction in sales, negative returns on capital, and a complete lack of cash generation or dividend distribution, painting a picture of a company in a deep operational and financial decline.